Apontis Pharma AG (APPH) — Cash Flow Reinvestment Rate
Apontis Pharma AG (APPH) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting €5.60K (capex €5.60K ) from operating cash flow of €905.24K. See cash generation quality of Apontis Pharma AG to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apontis Pharma AG Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Apontis Pharma AG across 3 annual periods. For the full cash flow conversion analysis, see Apontis Pharma AG (APPH) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Apontis Pharma AG (2020–2022)
Year-by-year capital reinvestment analysis for Apontis Pharma AG. See APPH free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.54x | €5.96 Million | €11.02 Million | €3.28 Million | ▼ -45.9% |
| 2021 | 1.00x | €3.43 Million | €3.43 Million | €1.66 Million | ▼ -3.7% |
| 2020 | 1.04x | €1.51 Million | €1.45 Million | €729.56K | — |